In the last trading session, 1.47 million shares of the Heron Therapeutics Inc (NASDAQ:HRTX) were traded, and its beta was 1.37. Most recently the company’s share price was $2.43, and it changed around $0.05 or 2.10% from the last close, which brings the market valuation of the company to $370.16M. HRTX currently trades at a discount to its 52-week high of $3.93, offering almost -61.73% off that amount. The share price’s 52-week low was $1.04, which indicates that the current value has risen by an impressive 57.2% since then. We note from Heron Therapeutics Inc’s average daily trading volume that its 10-day average is 1.7 million shares, with the 3-month average coming to 1.82 million.
Heron Therapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 3 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended HRTX as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight.
Heron Therapeutics Inc (NASDAQ:HRTX) trade information
Instantly HRTX has showed a green trend with a performance of 2.10% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 2.56 on recent trading dayincreased the stock’s daily price by 5.08%. The company’s shares are currently up 58.82% year-to-date, but still up 1.67% over the last five days. On the other hand, Heron Therapeutics Inc (NASDAQ:HRTX) is 40.46% up in the 30-day period. We can see from the shorts that 31.33 million shares have been sold at a short interest cover period of 15.9 day(s).
The consensus price target as assigned by Wall Street analysts is $7, which translates to bulls needing to increase their stock price by 65.29% from its current value. Analyst projections state that HRTX is forecast to be at a low of $5 and a high of $9.
Heron Therapeutics Inc (NASDAQ:HRTX)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.77% of Heron Therapeutics Inc shares, and 76.85% of them are in the hands of institutional investors. The stock currently has a share float of 77.45%. Heron Therapeutics Inc stock is held by 202.0 institutions, with RUBRIC CAPITAL MANAGEMENT LP being the largest institutional investor. By 2024-06-30, it held 17.5395% of the shares, which is about 26.71 million shares worth $93.5 million.
VANGUARD GROUP INC, with 5.6984% or 8.62 million shares worth $30.16 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF were the top two Mutual Funds as of Dec 31, 2024 . The former held 4.68 shares worth $11.38 million, making up 3.07% of all outstanding shares. On the other hand, iShares Russell 2000 ETF held roughly 3.19 shares worth around $7.75 million, which represents about 2.09% of the total shares outstanding.
